336 related articles for article (PubMed ID: 34260721)
21.
Lucena-Cacace A; Otero-Albiol D; Jiménez-García MP; Muñoz-Galvan S; Carnero A
Clin Cancer Res; 2018 Mar; 24(5):1202-1215. PubMed ID: 29203587
[No Abstract] [Full Text] [Related]
22. Perturbations of NAD
Agerholm M; Dall M; Jensen BAH; Prats C; Madsen S; Basse AL; Graae AS; Risis S; Goldenbaum J; Quistorff B; Larsen S; Vienberg SG; Treebak JT
Am J Physiol Endocrinol Metab; 2018 Apr; 314(4):E377-E395. PubMed ID: 29208611
[TBL] [Abstract][Full Text] [Related]
23. Nicotinamide phosphoribosyltransferase promotes epithelial-to-mesenchymal transition as a soluble factor independent of its enzymatic activity.
Soncini D; Caffa I; Zoppoli G; Cea M; Cagnetta A; Passalacqua M; Mastracci L; Boero S; Montecucco F; Sociali G; Lasigliè D; Damonte P; Grozio A; Mannino E; Poggi A; D'Agostino VG; Monacelli F; Provenzani A; Odetti P; Ballestrero A; Bruzzone S; Nencioni A
J Biol Chem; 2014 Dec; 289(49):34189-204. PubMed ID: 25331943
[TBL] [Abstract][Full Text] [Related]
24. Mechanism of Allosteric Modulation of Nicotinamide Phosphoribosyltransferase to Elevate Cellular NAD
Ratia KM; Shen Z; Gordon-Blake J; Lee H; Laham MS; Krider IS; Christie N; Ackerman-Berrier M; Penton C; Knowles NG; Musku SR; Fu J; Velma GR; Xiong R; Thatcher GRJ
Biochemistry; 2023 Feb; 62(4):923-933. PubMed ID: 36746631
[TBL] [Abstract][Full Text] [Related]
25. Subcellular NAMPT-mediated NAD
Wang X; Zhang Z; Zhang N; Li H; Zhang L; Baines CP; Ding S
J Neurochem; 2019 Dec; 151(6):732-748. PubMed ID: 31553812
[TBL] [Abstract][Full Text] [Related]
26. Increasing NAD synthesis in muscle via nicotinamide phosphoribosyltransferase is not sufficient to promote oxidative metabolism.
Frederick DW; Davis JG; Dávila A; Agarwal B; Michan S; Puchowicz MA; Nakamaru-Ogiso E; Baur JA
J Biol Chem; 2015 Jan; 290(3):1546-58. PubMed ID: 25411251
[TBL] [Abstract][Full Text] [Related]
27. Novel carbon skeletons activate human NicotinAMide Phosphoribosyl Transferase (NAMPT) enzyme in biochemical assay.
Almeida KH; Avalos-Irving L; Berardinelli S; Chauvin K; Yanez S
PLoS One; 2023; 18(3):e0283428. PubMed ID: 36996070
[TBL] [Abstract][Full Text] [Related]
28. NAMPT-derived NAD+ fuels PARP1 to promote skin inflammation through parthanatos cell death.
Martínez-Morcillo FJ; Cantón-Sandoval J; Martínez-Navarro FJ; Cabas I; Martínez-Vicente I; Armistead J; Hatzold J; López-Muñoz A; Martínez-Menchón T; Corbalán-Vélez R; Lacal J; Hammerschmidt M; García-Borrón JC; García-Ayala A; Cayuela ML; Pérez-Oliva AB; García-Moreno D; Mulero V
PLoS Biol; 2021 Nov; 19(11):e3001455. PubMed ID: 34748530
[TBL] [Abstract][Full Text] [Related]
29. Targeting NAD metabolism regulates extracellular adenosine levels to improve the cytotoxicity of CD8+ effector T cells in the tumor microenvironment of gastric cancer.
Liu HY; Wang FH; Liang JM; Xiang YY; Liu SH; Zhang SW; Zhu CM; He YL; Zhang CH
J Cancer Res Clin Oncol; 2023 Jul; 149(7):2743-2756. PubMed ID: 35776198
[TBL] [Abstract][Full Text] [Related]
30. Targeting the vulnerability to NAD
Takao S; Chien W; Madan V; Lin DC; Ding LW; Sun QY; Mayakonda A; Sudo M; Xu L; Chen Y; Jiang YY; Gery S; Lill M; Park E; Senapedis W; Baloglu E; Müschen M; Koeffler HP
Leukemia; 2018 Mar; 32(3):616-625. PubMed ID: 28904384
[TBL] [Abstract][Full Text] [Related]
31. Identification of novel resistance mechanisms to NAMPT inhibition via the de novo NAD
Guo J; Lam LT; Longenecker KL; Bui MH; Idler KB; Glaser KB; Wilsbacher JL; Tse C; Pappano WN; Huang TH
Biochem Biophys Res Commun; 2017 Sep; 491(3):681-686. PubMed ID: 28756225
[TBL] [Abstract][Full Text] [Related]
32. NAMPT suppresses glucose deprivation-induced oxidative stress by increasing NADPH levels in breast cancer.
Hong SM; Park CW; Kim SW; Nam YJ; Yu JH; Shin JH; Yun CH; Im SH; Kim KT; Sung YC; Choi KY
Oncogene; 2016 Jul; 35(27):3544-54. PubMed ID: 26568303
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological inhibition of nicotinamide phosphoribosyltransferase (NAMPT), an enzyme essential for NAD+ biosynthesis, in human cancer cells: metabolic basis and potential clinical implications.
Tan B; Young DA; Lu ZH; Wang T; Meier TI; Shepard RL; Roth K; Zhai Y; Huss K; Kuo MS; Gillig J; Parthasarathy S; Burkholder TP; Smith MC; Geeganage S; Zhao G
J Biol Chem; 2013 Feb; 288(5):3500-11. PubMed ID: 23239881
[TBL] [Abstract][Full Text] [Related]
34. Anticancer Activities of Novel Nicotinamide Phosphoribosyltransferase Inhibitors in Hematological Malignancies.
Biniecka P; Matsumoto S; Belotti A; Joussot J; Bai JF; Majjigapu SR; Thoueille P; Spaggiari D; Desfontaine V; Piacente F; Bruzzone S; Cea M; Decosterd LA; Vogel P; Nencioni A; Duchosal MA; Nahimana A
Molecules; 2023 Feb; 28(4):. PubMed ID: 36838885
[TBL] [Abstract][Full Text] [Related]
35. AMPK phosphorylates NAMPT to regulate NAD
Liao X; Huang X; Li X; Qiu X; Li M; Liu R; He T; Tang Q
Open Biol; 2022 Oct; 12(10):220213. PubMed ID: 36196536
[TBL] [Abstract][Full Text] [Related]
36. Discovery of Dual Function Agents That Exhibit Anticancer Activity via Catastrophic Nicotinamide Adenine Dinucleotide Depletion.
Fu Y; Huang Y; Zhou C; Li X; Dong G; Huang M; Ding J; Sheng C
J Med Chem; 2023 Dec; 66(24):16694-16703. PubMed ID: 38060985
[TBL] [Abstract][Full Text] [Related]
37. MiR-613 Promotes Cell Death in Breast Cancer Cells by Downregulation of Nicotinamide Phosphoribosyltransferase and Reduction of NAD.
Alizadeh-Fanalou S; Hosseinkhani S; Nazarizadeh A; Ezzati-Mobaser S; Hesari Z; Aziminezhadan P; Abdolvahabi Z; Abolmaali M; Tavakoli-Yaraki M; Nourbakhsh M
DNA Cell Biol; 2021 Jul; 40(7):1026-1036. PubMed ID: 34101492
[TBL] [Abstract][Full Text] [Related]
38. An NAD+-dependent transcriptional program governs self-renewal and radiation resistance in glioblastoma.
Gujar AD; Le S; Mao DD; Dadey DY; Turski A; Sasaki Y; Aum D; Luo J; Dahiya S; Yuan L; Rich KM; Milbrandt J; Hallahan DE; Yano H; Tran DD; Kim AH
Proc Natl Acad Sci U S A; 2016 Dec; 113(51):E8247-E8256. PubMed ID: 27930300
[TBL] [Abstract][Full Text] [Related]
39. Targeting of NAD metabolism in pancreatic cancer cells: potential novel therapy for pancreatic tumors.
Chini CC; Guerrico AM; Nin V; Camacho-Pereira J; Escande C; Barbosa MT; Chini EN
Clin Cancer Res; 2014 Jan; 20(1):120-30. PubMed ID: 24025713
[TBL] [Abstract][Full Text] [Related]
40. Notoginseng Leaf Triterpenes Ameliorates OGD/R-Induced Neuronal Injury via SIRT1/2/3-Foxo3a-MnSOD/PGC-1
Xie W; Zhu T; Zhou P; Xu H; Meng X; Ding T; Nan F; Sun G; Sun X
Oxid Med Cell Longev; 2020; 2020():7308386. PubMed ID: 33149812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
